Page last updated: 2024-09-02

ecopipam and Obesity

ecopipam has been researched along with Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Astrup, A; Greenway, FL; Kwan, R; Lachowicz, J; Ling, W; Pedicone, L; Strader, CD1

Trials

1 trial(s) available for ecopipam and Obesity

ArticleYear
Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects.
    Obesity (Silver Spring, Md.), 2007, Volume: 15, Issue:7

    Topics: Adolescent; Adult; Aged; Benzazepines; Body Mass Index; Diabetes Mellitus, Type 2; Dopamine Antagonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Obesity; Patient Selection; Placebos; Weight Loss

2007